Literature DB >> 15635701

Identification and characterization of human NR4A2 polymorphisms in attention deficit hyperactivity disorder.

Karen Müller Smith1, Lorri Bauer, Mariellen Fischer, Russell Barkley, Bradford A Navia.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is a highly heritable and common disorder thought to arise, in part, from alterations in dopamine function. NR4A2, or Nurr1, is an orphan nuclear receptor implicated in the development of dopaminergic cells of the ventral tegmental area (VTA) and the substantia nigra (SN). Dopaminergic cells of the VTA provide innervation to the prefrontal cortex, believed to be of major importance in the etiology of ADHD, suggesting that NR4A2 is a potential candidate gene for ADHD susceptibility. This study aimed to identify polymorphisms in NR4A2 and test their association to ADHD. Database analysis revealed a CA repeat polymorphism in the 3' UTR of NR4A2 that was confirmed by PCR. SSCP screening revealed a common DeltaC polymorphism, 254 bp 5' to the transcriptional start site. These polymorphisms were tested for an association with ADHD in both a case control study of individuals from the Milwaukee Longitudinal Study of ADHD (103 cases and 66 controls), and in 35 families composed of trios or affected sib pairs (ASP) with ADHD. Functional effects of the promoter polymorphism were tested in vitro. The non-deleted allele was significantly more active in undifferentiated SK-N-MC cells compared to differentiated SK-N-MC and HeLa cells while a trend for increased activity for the DeltaC allele was observed in undifferentiated SK-N-MC cells. Identification of these polymorphisms may aid future candidate gene studies in disorders with altered dopamine signaling, such as schizophrenia Parkinson's disease and ADHD. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15635701     DOI: 10.1002/ajmg.b.30127

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  13 in total

1.  Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats.

Authors:  Tomasz Schneider; Nicholas Ilott; Giovana Brolese; Lisiane Bizarro; Philip J E Asherson; Ian P Stolerman
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

2.  Epigenetic signature for attention-deficit/hyperactivity disorder: identification of miR-26b-5p, miR-185-5p, and miR-191-5p as potential biomarkers in peripheral blood mononuclear cells.

Authors:  Cristina Sánchez-Mora; María Soler Artigas; Iris Garcia-Martínez; Mireia Pagerols; Paula Rovira; Vanesa Richarte; Montse Corrales; Christian Fadeuilhe; Natàlia Padilla; Xavier de la Cruz; Barbara Franke; Alejandro Arias-Vásquez; Miguel Casas; Josep-Antoni Ramos-Quiroga; Marta Ribasés
Journal:  Neuropsychopharmacology       Date:  2018-12-19       Impact factor: 7.853

Review 3.  A review of psychostimulant-induced neuroadaptation in developing animals.

Authors:  Normand Carrey; Michael Wilkinson
Journal:  Neurosci Bull       Date:  2011-06       Impact factor: 5.203

4.  Comparison of different methods for DNA-free RNA isolation from SK-N-MC neuroblastoma.

Authors:  Lucélia Tavares; Paula M Alves; Ricardo B Ferreira; Claudia N Santos
Journal:  BMC Res Notes       Date:  2011-01-06

5.  Mutation and evolutionary analyses identify NR2E1-candidate-regulatory mutations in humans with severe cortical malformations.

Authors:  R A Kumar; S Leach; R Bonaguro; J Chen; D W Yokom; B S Abrahams; L Seaver; C E Schwartz; W Dobyns; A Brooks-Wilson; E M Simpson
Journal:  Genes Brain Behav       Date:  2006-11-29       Impact factor: 3.449

6.  Hippocampal Transcriptomic and Proteomic Alterations in the BTBR Mouse Model of Autism Spectrum Disorder.

Authors:  Caitlin M Daimon; Joan M Jasien; William H Wood; Yongqing Zhang; Kevin G Becker; Jill L Silverman; Jacqueline N Crawley; Bronwen Martin; Stuart Maudsley
Journal:  Front Physiol       Date:  2015-11-24       Impact factor: 4.566

7.  Rhynchophylline Downregulates Phosphorylated cAMP Response Element Binding Protein, Nuclear Receptor-related-1, and Brain-derived Neurotrophic Factor Expression in the Hippocampus of Ketamine-induced Conditioned Place Preference Rats.

Authors:  Youli Guo; Chaohua Luo; Genghong Tu; Chan Li; Yi Liu; Wei Liu; Ken Kin Lam Yung; Zhixian Mo
Journal:  Pharmacogn Mag       Date:  2018-02-20       Impact factor: 1.085

8.  Correlations of gene expression with ratings of inattention and hyperactivity/impulsivity in Tourette syndrome: a pilot study.

Authors:  Yingfang Tian; Boryana Stamova; Bradley P Ander; Glen C Jickling; Joan R Gunther; Blythe A Corbett; Netty G P Bos-Veneman; Pieter J Hoekstra; Julie B Schweitzer; Frank R Sharp
Journal:  BMC Med Genomics       Date:  2012-10-30       Impact factor: 3.063

9.  Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays.

Authors:  Kwang Ho Choi; Michael Elashoff; Brandon W Higgs; Jonathan Song; Sanghyeon Kim; Sarven Sabunciyan; Suad Diglisic; Robert H Yolken; Michael B Knable; E Fuller Torrey; Maree J Webster
Journal:  BMC Psychiatry       Date:  2008-11-07       Impact factor: 3.630

10.  Attention-deficit-hyperactivity disorder and reward deficiency syndrome.

Authors:  Kenneth Blum; Amanda Lih-Chuan Chen; Eric R Braverman; David E Comings; Thomas J H Chen; Vanessa Arcuri; Seth H Blum; Bernard W Downs; Roger L Waite; Alison Notaro; Joel Lubar; Lonna Williams; Thomas J Prihoda; Tomas Palomo; Marlene Oscar-Berman
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.